KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non Operating Income (2016 - 2017)

Jazz Pharmaceuticals (JAZZ) has 3 years of Non Operating Income data on record, last reported at -$1.5 million in Q1 2017.

  • For Q1 2017, Non Operating Income fell 78.75% year-over-year to -$1.5 million; the TTM value through Mar 2017 reached -$3.0 million, down 87.28%, while the annual FY2015 figure was $1.4 million, 83.36% down from the prior year.
  • Non Operating Income reached -$1.5 million in Q1 2017 per JAZZ's latest filing, down from -$749000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.2 million in Q1 2015 and bottomed at -$1.9 million in Q2 2015.
  • Average Non Operating Income over 3 years is -$226714.3, with a median of -$819000.0 recorded in 2016.
  • The widest YoY moves for Non Operating Income: up 23.34% in 2016, down 136.48% in 2016.
  • A 3-year view of Non Operating Income shows it stood at $2.1 million in 2015, then tumbled by 135.82% to -$749000.0 in 2016, then plummeted by 95.46% to -$1.5 million in 2017.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$1.5 million in Q1 2017, -$749000.0 in Q3 2016, and -$819000.0 in Q1 2016.